Vol 14, No 4 (April 30, 2025): Gland Surgery

Editorial

The role of robot-assisted mastectomy: promise, challenges, and evidence gaps
Mariam Rizk, Kefah Mokbel
Gland Surgery  
2025;
14
(4)
:579-583
.

Original Article

Malignant risk prediction of cystic-solid thyroid nodules using a comprehensive model integrating clinical and ultrasound features, ultrasound radiomics, and deep transfer learning
Rongwei Liu, Haiyuan Li, Changwen Liu, Jinbo Peng, Ruizhi Gao, Hong Yang, Yun He
Gland Surgery  
2025;
14
(4)
:584-596
.
Value of dynamic contrast-enhanced ultrasound in predicting cervical lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto’s thyroiditis
Kairen Zhang, Dan Zhao, Ying Song, Xiaofeng Wu, Chenyang Jin, Fenglin Dong
Gland Surgery  
2025;
14
(4)
:597-610
.
Fluorescent intraoperative tissue angiography during breast reduction: a single institution, single surgeon study evaluating decrease in complication rates with acquired proficiency
Jillian A. Smith, Scott Sylvester, Daniel Norez, William D. Kelly, Hugues Touze, Kristina M. Crawford, Brian G. Celso, John D. Murray
Gland Surgery  
2025;
14
(4)
:611-617
.
Serum thyroid-stimulating hormone as a diagnostic marker for cancer in atypia of undetermined significance/follicular lesion of undetermined significance nodules
Saad M. Alqahtani, Bassam A. Altalhi, Shehata F. Shehata, Yousef S. Alalawi, Saif S. Al-Sobhi
Gland Surgery  
2025;
14
(4)
:618-627
.
Correlation study of tumor-infiltrating lymphocytes (TILs) and subtypes analysis before and after neoadjuvant chemotherapy in triple-negative breast cancer
Yan Zhao, Si-Juan Jiang, Jin-Lu Wang, Zong-Yu Xie, Xin Jin
Gland Surgery  
2025;
14
(4)
:628-645
.
Unveiling the enigma: understanding the complex disease course of granulomatous mastitis and seeking ways to shorten it
Jia Liu, Wei-Yi Lin, Qiu-Zhou Wang, Xiao-Qin Yang, Qing Lv, Qiu-Wen Tan
Gland Surgery  
2025;
14
(4)
:646-657
.
Development and validation of an intratumoral-peritumoral deep transfer learning fusion model for differentiating BI-RADS 3–4 breast nodules
Lin Shi, Xinpeng Liu, Jinyu Lai, Feng Lu, Liping Gu, Lichang Zhong
Gland Surgery  
2025;
14
(4)
:658-669
.
The development and validation of biomarkers-based scoring systems for predicting early recurrence in patients with borderline resectable pancreatic cancer undergoing resection after neoadjuvant therapy
Hang He, Cai-Feng Zou, Yong-Jian Jiang, Feng Yang, Yang Di, Ji Li, Chen Jin, De-Liang Fu
Gland Surgery  
2025;
14
(4)
:670-686
.
Development and validation of a screening model for benign and malignant breast masses based on S-Detect and microvascular flow imaging
Zhongguang Hou, Yunyun Zhan, Jiajia Wang, Mei Peng
Gland Surgery  
2025;
14
(4)
:687-698
.
A web-based predictive model for secondary skin infections in breast cancer patients undergoing reconstruction
Xuni Xu, Wanying Chen, Gaoyi Wang, Yaqin Zhou, Wenkai Pan, Yu Zhou, Wei Zhang
Gland Surgery  
2025;
14
(4)
:699-713
.
Recent changes in surgical outcomes and preoperative biliary drainage with the increased use of neoadjuvant chemotherapy in pancreatic cancer patients undergoing pancreatoduodenectomy: a single-center retrospective study
Naoya Imamura, Atsushi Nanashima, Yuki Tsuchimochi, Takeomi Hamada, Hiroshi Kawakami, Masahide Hiyoshi
Gland Surgery  
2025;
14
(4)
:714-725
.
Correlation between ultrasound-based hepatic steatosis grade and thyroid hormone levels
Xuanxuan Zhang, Meijuan Jiang, Wei Zhu, Shouxing Xu, Wenqian Wang, Bin Ying, Xiaoting Chen, Shanshan Zhang, Jianlian Pan, Kai Zhang, Frank Tacke, Ju Dong Yang, Jian Chen
Gland Surgery  
2025;
14
(4)
:726-737
.
Development and validation of a multivariable risk model based on clinicopathological characteristics, mammography, and MRI imaging features for predicting axillary lymph node metastasis in patients with upgraded ductal carcinoma in situ
Min-Yi Cheng, Can-Gui Wu, Ying-Yi Lin, Jia-Chen Zou, Dong-Qing Wang, Bruce G. Haffty, Kun Wang
Gland Surgery  
2025;
14
(4)
:738-753
.

Editorial Commentary

Critical appraisal of the 2 mm threshold in ductal carcinoma in situ: methodological concerns in meta-analysis of margin width and local recurrence risk
Mariam Rizk, Muharrem Oner, Kefah Mokbel
Gland Surgery  
2025;
14
(4)
:771-775
.
Should abemaciclib candidacy be an indication for ALND?—commentary on SENOMAC post-hoc analysis
Jasmine C. Walker, Amanda L. Kong, Chandler S. Cortina
Gland Surgery  
2025;
14
(4)
:776-780
.
Risking arm lymphedema in more than a hundred patients to benefit one patient—is it worth it?
Geok Hoon Lim, Yoon-Sim Yap, Rui Jun Lim, Lester Chee Hao Leong
Gland Surgery  
2025;
14
(4)
:781-784
.
T-DM1: a promising adjuvant therapy option for stage I HER2-positive breast cancer—interpreting ATEMPT trial results from a clinical perspective
Meghana Kesireddy, Jairam Krishnamurthy
Gland Surgery  
2025;
14
(4)
:785-790
.
Dose-dense adjuvant chemotherapy for high-risk early breast cancer: its role in the era of personalised oncology
Constantinos Savva, Ramsey Cutress, Ellen Copson
Gland Surgery  
2025;
14
(4)
:791-796
.
Oncoplastic breast-conserving surgery: advancing oncological outcomes and aesthetic standards in breast cancer treatment
Umar Wazir, Kefah Mokbel
Gland Surgery  
2025;
14
(4)
:797-799
.